Miranda Smith
Engineered T cells show promise in fight against HIV
T cells that target HIV but are resistant to HIV infection are the latest strategy in the battle against HIV. Chimeric antigen receptor (CAR)-T cells are a concept also in development for treating cancer. Seattle researchers have published a new approach for developing CAR-T cells. This new strategy could eventually lead to better outcomes for people…
.png)